ACC-001
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for ACC-001, covering 2014-12-22 to 2021-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Long Term Extension Study Evaluating Safety, Tolerability and Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease [Phase 2]